loxapine has been researched along with Chronic Illness in 17 studies
Loxapine: An antipsychotic agent used in SCHIZOPHRENIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glycine was administered in an effort to facilitate endogenous glutamatergic transmission at the level of the N-methyl-D-aspartate (NMDA) receptor complex, since a glutamatergic deficiency in the pathophysiology of schizophrenia has been postulated." | 5.28 | Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study. ( Banay-Schwartz, M; Cohen, CG; Deutsch, SI; Leighton, M; Rosse, RB; Scarcella, E; Theut, SK, 1989) |
| " The average daily dosage was 81." | 2.64 | Loxapine versus perphenazine in psychotic patients. A double-blind, randomized, multicentre trial. ( Fensbo, C; Fruensgaard, K; Hansen, KM; Sihm, F; Wollenberg, J, 1978) |
| "Glycine was administered in an effort to facilitate endogenous glutamatergic transmission at the level of the N-methyl-D-aspartate (NMDA) receptor complex, since a glutamatergic deficiency in the pathophysiology of schizophrenia has been postulated." | 1.28 | Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study. ( Banay-Schwartz, M; Cohen, CG; Deutsch, SI; Leighton, M; Rosse, RB; Scarcella, E; Theut, SK, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (88.24) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Irwin, GE | 1 |
| Simon, JE | 1 |
| Athanassenas, G | 1 |
| Papadopoulos, E | 1 |
| Kourkoubas, A | 1 |
| Tsitourides, S | 1 |
| Gabriel, J | 1 |
| Hoïdas, S | 1 |
| Frangos, E | 1 |
| Branchey, MH | 3 |
| Branchey, LB | 1 |
| Richardson, MA | 1 |
| Ewing, DG | 1 |
| Einarson, TR | 1 |
| Mowerman, S | 1 |
| Siris, SG | 1 |
| Nair, NP | 1 |
| Decker, BL | 1 |
| Schwartz, G | 1 |
| Cottereau, MJ | 1 |
| Poirier, MF | 1 |
| Lôo, H | 1 |
| Deniker, P | 1 |
| Brebbia, DR | 1 |
| Cooper, TB | 1 |
| Simpson, GM | 2 |
| Fruensgaard, K | 1 |
| Wollenberg, J | 1 |
| Hansen, KM | 1 |
| Fensbo, C | 1 |
| Sihm, F | 1 |
| Ayd, FJ | 1 |
| Kiloh, LG | 1 |
| Williams, SE | 1 |
| Grant, DA | 1 |
| Whetton, PS | 1 |
| Vianna Filho, U | 1 |
| Versiani Caldeira, V | 1 |
| Romildo Bueno, J | 1 |
| Lee, JH | 1 |
| Varga, E | 1 |
| Clark, ML | 1 |
| Paredes, A | 1 |
| Costiloe, JP | 1 |
| Wood, F | 1 |
| Barrett, A | 1 |
| Lindenmayer, JP | 1 |
| Vakharia, M | 1 |
| Kanofsky, D | 1 |
| Rosse, RB | 1 |
| Theut, SK | 1 |
| Banay-Schwartz, M | 1 |
| Leighton, M | 1 |
| Scarcella, E | 1 |
| Cohen, CG | 1 |
| Deutsch, SI | 1 |
| Contreras, SA | 1 |
| Maas, JW | 1 |
| Seleshi, E | 1 |
| Bowden, CL | 1 |
1 review available for loxapine and Chronic Illness
| Article | Year |
|---|---|
Loxapine update: 1966-1976.
Topics: Acute Disease; Administration, Oral; Age Factors; Ambulatory Care; Antiparkinson Agents; Basal Gangl | 1977 |
8 trials available for loxapine and Chronic Illness
| Article | Year |
|---|---|
Serum calcium and magnesium levels in chronic schizophrenics.
Topics: Calcium; Chronic Disease; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Loxapine; Magnesiu | 1983 |
Effects of neuroleptic adjustment on clinical condition and tardive dyskinesia in schizophrenic patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Dibenzoxazepines; Double-Blind Method; Dyskinesia, | 1981 |
Adjunctive loxapine in a clozapine-resistant cohort of schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clozapine; Drug Therapy, Combination; Female; Humans; | 1996 |
Loxapine versus perphenazine in psychotic patients. A double-blind, randomized, multicentre trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Dibenzoxazepines; | 1978 |
A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients.
Topics: Acute Disease; Adult; Chronic Disease; Clinical Trials as Topic; Dibenzoxazepines; Double-Blind Meth | 1976 |
The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Chronic Disease; Clinical Trials as To | 1975 |
Loxapine in newly admitted chronic schizophrenic patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Dibenzoxazepines; Female; Humans; Loxapine; Male; | 1975 |
Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Apomorphine; Chronic Disease; Clinical Trials as Topic; Diben | 1988 |
8 other studies available for loxapine and Chronic Illness
| Article | Year |
|---|---|
Neuroleptic malignant syndrome.
Topics: Basal Ganglia Diseases; Chronic Disease; Diagnosis, Differential; Dibenzoxazepines; Dose-Response Re | 1984 |
Loxapine as an alternative to phenothiazines in a case of oculocutaneous skin pigmentation.
Topics: Chlorpromazine; Chronic Disease; Dibenzoxazepines; Eye Color; Humans; Loxapine; Male; Middle Aged; P | 1981 |
Loxapine succinate in the treatment of chronic schizophrenia.
Topics: Adult; Brief Psychiatric Rating Scale; Chronic Disease; Dibenzoxazepines; Drug Evaluation; Female; H | 1976 |
[Loxapine succinate: a new neuroleptic].
Topics: Adult; Basal Ganglia Diseases; Brief Psychiatric Rating Scale; Chronic Disease; Dibenzoxazepines; Dr | 1979 |
Effects of loxapine on the sleep of chronic schizophrenics.
Topics: Adult; Chronic Disease; Dibenzoxazepines; Female; Humans; Loxapine; Male; Middle Aged; Schizophrenic | 1979 |
A two year trial of loxapine succinate in chronic psychotic patients.
Topics: Adult; Basal Ganglia Diseases; Blood Pressure; Body Weight; Chronic Disease; Dibenzoxazepines; Femal | 1976 |
Fluoxetine in chronic schizophrenia.
Topics: Amantadine; Chronic Disease; Drug Therapy, Combination; Fluoxetine; Humans; Loxapine; Male; Middle A | 1990 |
Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Basal Ganglia Diseases; Benztropine; Chronic Disease; Cognitio | 1989 |